Posttransplant Diabetes Mellitus: Incidence and Risk Factors

Transplantation Proceedings

Volumn 40, Issue 3, 2008, Pages 764-766

  Mazali, F Cr ^a   Lalli, Cr A ^a   Alves Filho, G ^a   Mazzali, M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HLA DR ANTIGEN; HLA DR13 ANTIGEN; INSULIN; METFORMIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; GRAFT VERSUS HOST REACTION; HEPATITIS C; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; WEIGHT GAIN;

ADULT; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TACROLIMUS; TIME FACTORS; WEIGHT GAIN;

EID: 42949130286     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.018     Document Type: Article

References (12)

1. Morre R., Boucher A., Carter J., et al. Diabetes mellitus in transplantation: 2002 Consensus Guidelines. Transplant Proc 35 (2003) 1265
2. Ersoy A., Ersoy C., Tekce H., et al. Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus. Transplant Proc 36 (2004) 1407
3. Van Duijnhoven E.M., Boots J.M., Christiaans M.H.L., et al. Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study. J Am Soc Nephrol 12 (2001) 583
4. Araki M., Flechner S.M., Ismail H.R., et al. Posttransplantation diabetes mellitus in kidney transplantrecipients receiving calcineurin or mTor inhibitor drugs. Transplantation 81 (2006) 335
5. Sato T., Inagaki A., Uchid K., et al. Diabetes mellitus after transplant: Relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A base theray. Transplantation 76 (2003) 1320
6. Hur K.Y., Kim M.S., Kim Y.S., et al. Risk factors associated with the onset and progression of posttransplant diabetes in renal allograft recipients. Diabetes Care 30 (2007) 609
7. Kamar N., Mariat C., Delahousse M., et al. Diabetes mellitus after kidney transplantation: a French multicentre observational study. Nephrol Dial Transplant 22 (2007) 1986
8. Shah T., Kasravi A., Huang E., et al. Risk factors development of new onset diabetes mellitus after kidney transplantation. Transplantation 82 (2006) 1673
9. Vincenti F., Friman S., Scheuermann E., et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 7 (2007) 1506
10. Joss N., Staatz C.E., Thomson A.H., et al. Predictors of new onset diabetes after renal transplantation. Clin Transplant 21 (2007) 136
11. Hoitsma A.J., and Hilbrands L.B. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression. Clin Transplant 20 (2006) 659
12. Finni P.E.S., Souza E.R.M., Rioja S., et al. Is hepatitis C a risk factor to posttransplant diabetes mellitus after renal transplantation in patients using tacrolimus?. Transplant Proc 36 (2004) 884